Rare Disease Treatments
Pharmaceutical and biotech companies developing orphan drugs and therapies for rare diseases affecting small patient populations
Symbols
LLYLilly(Eli) & CoMarket Cap: $1T
ABBVAbbvie IncMarket Cap: $381.1B
NOVNNovartis AGMarket Cap: $290.1B
NVONovo NordiskMarket Cap: $202.8B
AMGNAMGEN Inc.Market Cap: $183.1B
BRMBristol-Myers Squibb Co.Market Cap: $121.4B
BMYBristol-Myers Squibb Co.Market Cap: $121.4B
VRTXVertex Pharmaceuticals, Inc.Market Cap: $110.3B
REGNRegeneron Pharmaceuticals, Inc.Market Cap: $67B
SNYSanofiMarket Cap: $54B
ARGXArgen X SEMarket Cap: $49.9B
ALNYAlnylam Pharmaceuticals IncMarket Cap: $39.7B
EDGGold Fields LtdMarket Cap: $35.4B
BDRXBiodexa Pharmaceuticals PlcMarket Cap: $29.6B
BIIBBiogen IncMarket Cap: $28.6B
TAKTakeda Pharmaceutical CoMarket Cap: $27.6B
ZLABZai Lab LimitedMarket Cap: $27.2B
UTHRUnited Therapeutics CorpMarket Cap: $24.1B
INSMInsmed IncMarket Cap: $23B
ROIVRoivant Sciences LtdMarket Cap: $21.5B